191 related articles for article (PubMed ID: 30004053)
1. Immunohistochemical expression profiles of MUC1 and MUC2 mucins in urothelial tumors of bladder.
Gonul II; Cakir A; Sozen S
Indian J Pathol Microbiol; 2018; 61(3):350-355. PubMed ID: 30004053
[TBL] [Abstract][Full Text] [Related]
2. Mucin expression by transitional cell carcinomas of the bladder.
Walsh MD; Hohn BG; Thong W; Devine PL; Gardiner RA; Samaratunga ML; McGuckin MA
Br J Urol; 1994 Mar; 73(3):256-62. PubMed ID: 8162502
[TBL] [Abstract][Full Text] [Related]
3. Expression of epithelial mucins Muc1, Muc2, and Muc3 in ductal carcinoma in situ of the breast.
Diaz LK; Wiley EL; Morrow M
Breast J; 2001; 7(1):40-5. PubMed ID: 11348414
[TBL] [Abstract][Full Text] [Related]
4. Expression of MUC1 (Ma695) in noninvasive papillary urothelial neoplasm according to the 2004 World Health Organization classification of the noninvasive urothelial neoplasm. An immunologic tool for the pathologist?
Garbar C; Mascaux C
Anal Quant Cytol Histol; 2011 Oct; 33(5):277-82. PubMed ID: 22611755
[TBL] [Abstract][Full Text] [Related]
5. Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas.
Baldus SE; Zirbes TK; Engel S; Hanisch FG; Mönig SP; Lorenzen J; Glossmann J; Fromm S; Thiele J; Pichlmaier H; Dienes HP
Int J Cancer; 1998 Apr; 79(2):133-8. PubMed ID: 9583726
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of transmembrane mucins, MUC1 and MUC4, in bladder cancer: pathological implications in diagnosis.
Kaur S; Momi N; Chakraborty S; Wagner DG; Horn AJ; Lele SM; Theodorescu D; Batra SK
PLoS One; 2014; 9(3):e92742. PubMed ID: 24671186
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of mucin 1 and mucin 2 in colorectal cancer.
Kasprzak A; Siodła E; Andrzejewska M; Szmeja J; Seraszek-Jaros A; Cofta S; Szaflarski W
World J Gastroenterol; 2018 Sep; 24(36):4164-4177. PubMed ID: 30271081
[TBL] [Abstract][Full Text] [Related]
8. Expression of MUC1 and MUC2 mucin gene products in human ovarian carcinomas.
Feng H; Ghazizadeh M; Konishi H; Araki T
Jpn J Clin Oncol; 2002 Dec; 32(12):525-9. PubMed ID: 12578901
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of MUC1 and MUC2 mucin and p53 protein expression in colorectal carcinoma.
Matsuda K; Masaki T; Watanabe T; Kitayama J; Nagawa H; Muto T; Ajioka Y
Jpn J Clin Oncol; 2000 Feb; 30(2):89-94. PubMed ID: 10768872
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of mucin expression in urothelial bladder cancer.
Stojnev S; Ristic-Petrovic A; Velickovic LJ; Krstic M; Bogdanovic D; Khanh do T; Ristic A; Conic I; Stefanovic V
Int J Clin Exp Pathol; 2014; 7(8):4945-58. PubMed ID: 25197366
[TBL] [Abstract][Full Text] [Related]
11. Associations between the expression of mucins (MUC1, MUC2, MUC5AC and MUC6) and clinicopathologic parameters of human breast carcinomas.
Oral O; Unverdi H; Kumcu E; Turkbey D; Dogan S; Hucumenoglu S
Indian J Pathol Microbiol; 2020; 63(4):551-558. PubMed ID: 33154304
[TBL] [Abstract][Full Text] [Related]
12. MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration.
Chhieng DC; Benson E; Eltoum I; Eloubeidi MA; Jhala N; Jhala D; Siegal GP; Grizzle WE; Manne U
Cancer; 2003 Dec; 99(6):365-71. PubMed ID: 14681945
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of MUC1, MUC2 and MUC5AC expressions in gastric carcinoma.
İlhan Ö; Han Ü; Önal B; Çelık SY
Turk J Gastroenterol; 2010 Dec; 21(4):345-52. PubMed ID: 21331986
[TBL] [Abstract][Full Text] [Related]
14. Differential mucin MUC7 gene expression in invasive bladder carcinoma in contrast to uniform MUC1 and MUC2 gene expression in both normal urothelium and bladder carcinoma.
Retz M; Lehmann J; Röder C; Plötz B; Harder J; Eggers J; Pauluschke J; Kalthoff H; Stöckle M
Cancer Res; 1998 Dec; 58(24):5662-6. PubMed ID: 9865718
[TBL] [Abstract][Full Text] [Related]
15. Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: its relationship with tumor progression and prognosis.
Tamada S; Goto M; Nomoto M; Nagata K; Shimizu T; Tanaka S; Sakoda K; Imai K; Yonezawa S
Pathol Int; 2002 Nov; 52(11):713-23. PubMed ID: 12685548
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of MUC1, MUC2 and MUC5AC in colorectal carcinoma and review of literature.
Kesari MV; Gaopande VL; Joshi AR; Babanagare SV; Gogate BP; Khadilkar AV
Indian J Gastroenterol; 2015 Jan; 34(1):63-7. PubMed ID: 25731647
[TBL] [Abstract][Full Text] [Related]
17. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.
Utsunomiya T; Yonezawa S; Sakamoto H; Kitamura H; Hokita S; Aiko T; Tanaka S; Irimura T; Kim YS; Sato E
Clin Cancer Res; 1998 Nov; 4(11):2605-14. PubMed ID: 9829723
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of MUC1 and P53 expressions in noninvasive papillary urothelial neoplasms of bladder, their relationship with tumor grade and role in the differential diagnosis.
Kaymaz E; Ozer E; Unverdi H; Hucumenoglu S
Indian J Pathol Microbiol; 2017; 60(4):510-514. PubMed ID: 29323063
[TBL] [Abstract][Full Text] [Related]
19. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma.
Matsukita S; Nomoto M; Kitajima S; Tanaka S; Goto M; Irimura T; Kim YS; Sato E; Yonezawa S
Histopathology; 2003 Jan; 42(1):26-36. PubMed ID: 12493022
[TBL] [Abstract][Full Text] [Related]
20. Expression of mucin antigens in human cancers and its relationship with malignancy potential.
Yonezawa S; Sato E
Pathol Int; 1997 Dec; 47(12):813-30. PubMed ID: 9503463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]